An international research study has shown that, in animal models, type 2 insulin (IGF-II) growth factor reinforces memory and prevents forgetfulness.

Finally some good news for Type 2 Diabetics, drug makers Bristol-Myers Squibb and partners Astrazeneca PLC had their latest drug Onglyza approved. Onglyza reduces blood sugar levels in patients with type 2 diabetes, which affects 24 million people in the U.S. The drug is the first to gain approval since the agency issued new testing [...]

I always find myself curious to hear other diabetics stories discussing thing’s like; where they were when they found out, what symptoms they experiencing, if they didn’t notice any of the symptoms, what finally happened that made them aware of the disease… etc. Many people don’t enjoy going to the doctors office for every little [...]

Researchers from Duke University Medical Center have analyzed data from nearly 58,000 patients included in the Bariatric Outcomes Longitudinal Database (BOLD), the largest repository of medical information on people who’ve undergone the weight-loss surgery. Only about 10 percent had complications, according to the study, which was to be presented Wednesday at the annual meeting of [...]

Patients with Type 2 Diabetes may soon get a very different treatment approach: A drug that helps control blood sugar via the brain — an idea sparked, surprisingly, by the metabolism of migrating birds. The Food and Drug Administration approved Cycloset, maker VeroScience Inc announced. It’s a new version of an old drug called bromocriptine, [...]

      With the swine Flu grabbing the headlines lately I thought I would post some information about how we can avoid putting ourselves at risk. Since 1997 experts have warned us of a horrific worldwide influenza outbreak, when the first human cases of so-called H5N1 avian influenza were reported in Hong Kong.  Two [...]